An initiative of the Advancing Injectable Markets for Sustainability (AIMS) project

AIMS will award successful proposals up to US$200,000 for a 9-month award period.

The Advancing Injectable Markets for Sustainability (AIMS) project provides free data-driven technical assistance (TA), coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.

Partners can access TA by submitting a request to the AIMS team at FPoptions@path.org.

PATH has developed this comprehensive suite of scientific communications materials to support evidence-based introduction and scale-up of DMPA-SC and self-injection (SI).

This resource provides a high-level summary of the current state of self-injection policy development, implementation, and monitoring in each of the Injectables Access Collaborative’s 11 focus countries: Benin, DRC, Ghana, Kenya, Madagascar, Malawi, Mozambique, Nigeria, Togo, Uganda, and Zambia. The policy cycle landscape (i.e., policy development, implementation, and monitoring) features an overview of the enabling environment for self-injection in each country, including general self-injection and self-care policies, as well as local authorizations for task-sharing/task-shifting. The information is current as of Quarter 2, 2025.

PATH has compiled a list featuring presentations, posters, and events on the topic of DMPA-SC, including self-injection and self-care, to be featured at the International Conference on Family Planning on 3-6 November 2025. The list linked below includes nearly 70 abstracts highlighting the latest DMPA-SC research and implementation experience from a diverse array of partner organizations.

This webinar held on January 16, 2025 was hosted by the Injectables Access Collaborative Learning and Action Network in collaboration with the Reproductive Health Supplies Coalition’s (RHSC) New and Underused Reproductive Health Technologies Caucus (NURHT).  The discussion focused on advocacy strategies for reproductive health product introduction, scale-up, and institutionalization, emphasizing what it takes to see tangible change.

Presenters shared advocacy strategies and tactics that have successfully driven change—highlighting what is needed in the often-complex space between securing an advocacy win and seeing progress toward the desired outcome. Topics included increasing access to DMPA-SC self-injection, advancing menstrual health product standards, and facilitating country-level procurement of the hormonal intrauterine device (IUD).

This lesson is intended for health care providers learning to counsel family planning clients about DMPA-SC and self-injection in the context of informed choice. Developed by the Injectables Access Collaborative, the lesson incorporates key content from the more in-depth DMPA-SC self-injection empathy-based counseling developed by the PSI Delivering Innovation in Self-Care (DISC) project. The lesson can be incorporated into a comprehensive training on DMPA-SC or adapted as a refresher training for experienced providers.

Please contact FPoptions@path.org with questions or comments.

This brief describes the work of the Injectables Access Collaborative which provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming. The Access Collaborative is led by PATH in partnership with the Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, and JSI.

In collaboration with the Uganda Ministry of Health, PATH is leading the Private Sector Family Planning project (2023–2026) to strengthen the private sector market for family planning, paving the way for introduction of more contraceptive methods in commercial outlets, providing clients more options for where and how to access methods of their choice.

The Injectables Access Collaborative Learning and Action Network hosted this webinar on February 28, 2024 highlighting task-sharing provision of injectable contraception—including DMPA-SC and self-injection—through support from community health workers (CHWs). At least 13 countries now authorize CHWs to support clients’ initiation of self-injection at the community level. Participants learned about the latest data on DMPA-SC provision and self-injection support by CHWs, heard from ministry of health representatives and CHWs themselves about the practice and potential of task-sharing of self-care services, and reflected on how to strengthen community health programs to improve equitable access to integrated primary health care services, including an expanded range of family planning options.

This event is part of series on task-sharing along with this webinar on private sector access to DMPA-SC.